CSI Market
Sign In | Register

Ampio Pharmaceuticals inc (AMPE) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access AMPE Annual Cash Flow →
This page allows investors to follow Ampio Pharmaceuticals inc's cash flow patterns across multiple reporting periods and assess consistency in cash generation.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
12 Months 		(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Operating Activities
Income-8.63
Depreciation & amortization0.12
Amortization of Other Assets0.00
Asset Retirement Obligation, Accretion Expense0.01
Impairment of Long-Lived Assets Held-for-use0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.06
Share-based Compensation0.16
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Gain Loss On Derivative Instruments Net Pretax-
Amortization Of Prepaid Research And Development Due To Related Parties-
Increase Decrease In Prepaid Research And Development Due To Related Parties-
Warrant Modification Expense-
Availableforsale Securities Gross Unrealized Gain Loss-
Increase Decrease In Lease Liability-0.18
Share Based Payment Arrangement Forfeiture Restricted Stock-
Gain From Elimination And Accretion Of Aro Obligation Net-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Insurance Settlements Receivable-0.92
Increase (Decrease) in Accounts Payable and Accrued Liabilities1.25
Increase (Decrease) in Accrued Salaries0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expenses, Other-0.05
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-8.56
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Gross0.00
Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Increase (Decrease) in Deposits0.00
Other financing activities net0.00
Other net0.00
Proceeds From Common Stock Subscribed-
Payments Of Stock Issuance Costs Registered Direct Offering-
Proceeds From Issuance Of Common Stock Equity Distribution Agreement-
Payment Of Stock Issuance Costs Equity Distribution Agreement-
Proceeds From Issuance Of Common Stock Public Offering-
Payment Of Stock Issuance Costs Public Offering-
Proceeds From Sale Of Common Stock In Connection With At Market Equity Offering Program-
Payment Of Stock Issuance Costs At Market Equity Offering Program-
Payment Of Stock Issuance Cost Registered Direct Offering Monetary-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-8.56
Total Cash Flow-8.56
4 historic quarters locked

Sign in to unlock the full Ampio Pharmaceuticals inc cash flow history.

Sign In Create Free Account

About Ampio Pharmaceuticals Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001558370-24-004090

Figures are derived from filed reports and may be restated. Historical data is subject to revision.